Valentina Grazioli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Valentina Grazioli has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
Laura Giroletti
4 shared publicationsAlfonso Agnino
Division of Robotic and Minimally Invasive Cardiac Surgery, Department of Cardiovascular Surgery, Cliniche Humanitas Gavazzeni , 24125 Bergamo
3 shared publications- Domenico Corradi
Pathology Unit, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy
3 shared publications - Michele Di Mauro
Department of Cardiothoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre , P. Debyelaan, Maastricht 12–6221
3 shared publications Piersilvio Gerometta
Department of Cardiac Surgery, Cliniche Humanitas Gavazzeni , Bergamo
3 shared publicationsAscanio Graniero
2 shared publications
Latest Publications
- 5 February 2026
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 68 (2)
Endoscopic Combined Aortic and Mitral Valve Surgery: Feasibility and Mid-term Outcomes
Objectives: Endoscopic surgery has emerged as an evolution of minimally invasive approaches, but evidence regarding its application in combined valve procedures remains scarce. This study evaluates its feasibility and mid-term outcomes in concomitant aortic and mitral valve (MV) surgery. Methods: We retrospectively analysed all consecutive patients undergoing endoscopic concomitant mitral and aortic valve (AV) surgery from January 2016 to July 2025. Cardiopulmonary bypass (CPB) was established via peripheral cannulation. All procedures were performed through a right mini-thoracotomy using a 30° thoracoscope. The primary end-point was in-hospital mortality. Secondary end-points included major postoperative complications, a composite early outcome (in-hospital mortality, stroke, major bleeding requiring revision, postoperative myocardial infarction, or dialysis), and mid-term survival. Univariable logistic regression was used to identify predictors of the composite early postoperative outcome. Follow-up was 100% complete. Results: The analysis included 111 patients (median age 70 years [interquartile range, IQR 62-76], 55 males, median EuroSCORE II 3.3 [IQR 1.90-5.04]). The AV was replaced in all cases. Mitral valve was repaired in 54 cases and replaced in 57. Concomitant procedures were performed in 44 cases. Median CPB and cross-clamp times were 198 [164-233] and 139 [117-160] minutes, respectively. In-hospital mortality was 3.6%, with low rates of stroke (3.6%), bleeding (8.1%), and dialysis (5.4%). At a median follow-up of 46 months, overall survival was 87%. Reduced estimated glomerular filtration rate (eGFR), coronary artery disease, chronic lung disease, and peripheral arteriopathy were significantly associated with the composite early outcome. Conclusions: Endoscopic technique can be successfully applied to combined aortic and MV surgery, encouraging its broader adoption. IRB Number: 2020189, July 30, 2020.
- 5 February 2026
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 68 (2)
Endoscopic Combined Aortic and Mitral Valve Surgery: Feasibility and Mid-term Outcomes
Objectives: Endoscopic surgery has emerged as an evolution of minimally invasive approaches, but evidence regarding its application in combined valve procedures remains scarce. This study evaluates its feasibility and mid-term outcomes in concomitant aortic and mitral valve (MV) surgery. Methods: We retrospectively analysed all consecutive patients undergoing endoscopic concomitant mitral and aortic valve (AV) surgery from January 2016 to July 2025. Cardiopulmonary bypass (CPB) was established via peripheral cannulation. All procedures were performed through a right mini-thoracotomy using a 30° thoracoscope. The primary end-point was in-hospital mortality. Secondary end-points included major postoperative complications, a composite early outcome (in-hospital mortality, stroke, major bleeding requiring revision, postoperative myocardial infarction, or dialysis), and mid-term survival. Univariable logistic regression was used to identify predictors of the composite early postoperative outcome. Follow-up was 100% complete. Results: The analysis included 111 patients (median age 70 years [interquartile range, IQR 62-76], 55 males, median EuroSCORE II 3.3 [IQR 1.90-5.04]). The AV was replaced in all cases. Mitral valve was repaired in 54 cases and replaced in 57. Concomitant procedures were performed in 44 cases. Median CPB and cross-clamp times were 198 [164-233] and 139 [117-160] minutes, respectively. In-hospital mortality was 3.6%, with low rates of stroke (3.6%), bleeding (8.1%), and dialysis (5.4%). At a median follow-up of 46 months, overall survival was 87%. Reduced estimated glomerular filtration rate (eGFR), coronary artery disease, chronic lung disease, and peripheral arteriopathy were significantly associated with the composite early outcome. Conclusions: Endoscopic technique can be successfully applied to combined aortic and MV surgery, encouraging its broader adoption. IRB Number: 2020189, July 30, 2020.
- Open Access
- 24 September 2025
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 40 (10)
Histological Analysis of Arterial and Venous Grafts Used in Coronary Bypass for Patients With Renal Insufficiency: A Prospective Multicentre Observational Study
Objectives: Chronic kidney disease (CKD) is associated with metabolic dysfunctions that accelerate atherosclerosis, posing significant challenges for patients undergoing coronary artery bypass grafting (CABG). In this population, arterial calcification and reduced saphenous vein patency are common complications. This multicentre prospective study aims to evaluate the impact of renal dysfunction on the histological characteristics of arterial and venous grafts used in CABG. Methods: Vascular graft specimens collected during CABG were prospectively analysed and stratified into 3 groups based on renal function, according to established publications: Group 1 (glomerular filtration rate [GFR] ≥90 mL/min/1.73 m2), Group 2 (GFR 60-89 mL/min/1.73 m2), and Group 3 (GFR ≤59 mL/min/1.73 m2). Formalin-fixed samples were histologically assessed for intimal thickening (Grade 0-3), fibroelastosis, and vasa vasorum density. Results: A total of 324 arterial grafts (Group 1: 100; Group 2: 134; Group 3: 90) and 289 vein grafts (Group 1: 86; Group 2: 119; Group 3: 84) were analysed, including 5 arterial and venous grafts from dialysis patients. No significant structural differences were observed between groups. Intimal thickening rates were comparable across renal function stages. Fibroelastosis was more prevalent in venous grafts (56%-64%) than in arterial grafts (10%-15%). Conclusions: This study assesses graft histology in CABG patients stratified by renal function. At surgery, CKD does not appear to significantly alter graft structure. Further studies are warranted to explore long-term graft outcomes in this population.
- 24 September 2025
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 40 (10)
Open AccessHistological Analysis of Arterial and Venous Grafts Used in Coronary Bypass for Patients With Renal Insufficiency: A Prospective Multicentre Observational Study
Objectives: Chronic kidney disease (CKD) is associated with metabolic dysfunctions that accelerate atherosclerosis, posing significant challenges for patients undergoing coronary artery bypass grafting (CABG). In this population, arterial calcification and reduced saphenous vein patency are common complications. This multicentre prospective study aims to evaluate the impact of renal dysfunction on the histological characteristics of arterial and venous grafts used in CABG. Methods: Vascular graft specimens collected during CABG were prospectively analysed and stratified into 3 groups based on renal function, according to established publications: Group 1 (glomerular filtration rate [GFR] ≥90 mL/min/1.73 m2), Group 2 (GFR 60-89 mL/min/1.73 m2), and Group 3 (GFR ≤59 mL/min/1.73 m2). Formalin-fixed samples were histologically assessed for intimal thickening (Grade 0-3), fibroelastosis, and vasa vasorum density. Results: A total of 324 arterial grafts (Group 1: 100; Group 2: 134; Group 3: 90) and 289 vein grafts (Group 1: 86; Group 2: 119; Group 3: 84) were analysed, including 5 arterial and venous grafts from dialysis patients. No significant structural differences were observed between groups. Intimal thickening rates were comparable across renal function stages. Fibroelastosis was more prevalent in venous grafts (56%-64%) than in arterial grafts (10%-15%). Conclusions: This study assesses graft histology in CABG patients stratified by renal function. At surgery, CKD does not appear to significantly alter graft structure. Further studies are warranted to explore long-term graft outcomes in this population.
- Open Access
- 19 February 2025
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 40 (3)
Myocardial revascularization in patients with chronic kidney disease: a systematic review and meta-analysis of surgical versus percutaneous coronary revascularization
OBJECTIVES: To compare outcomes of two different revascularization strategies in chronic kidney disease (CKD) patients: coronary artery bypass grafting (CABG) versus percutaneous coronary intervention (PCI). METHODS: We conducted this meta-analysis according to Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines and registered with PROSPERO (CRD42021238659), evaluated studies comparing CABG and PCI in patients with CAD and CKD (defined by KDIGO guidelines). Data were extracted from PubMed, EMBASE and Cochrane from 2000 to 2023. The primary end-point was long-term major adverse cardiovascular and cerebrovascular event rates, with secondary end-points including 30-day mortality, stroke, myocardial infarction (MI) and repeat revascularization. Statistical analyses included Kaplan–Meier estimations, Cox regression, and meta-regression to address heterogeneity. Publication bias was assessed via funnel plots. No funding was received, and the authors report no conflicts of interest. RESULTS: We included 33 studies with 402 300 patients (eGFR <60 ml/min/1.73 m2). The cohort comprised 132 314 coronary artery bypass graft and 269 986 PCI patients. Over 3 years, coronary artery bypass group provided protection against major adverse cardiac and cerebrovascular events, MI, and repeat revascularization compared to PCI. However, PCI showed better short-term outcomes, including lower 30-day mortality. Coronary artery bypass group was linked to a higher stroke risk over the 3-year follow-up. CONCLUSIONS: Revascularization strategies for CKD and coronary artery disease patients should balance PCI's short-term benefits with CABG’s long-term advantages.
- 19 February 2025
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 40 (3)
Open AccessMyocardial revascularization in patients with chronic kidney disease: a systematic review and meta-analysis of surgical versus percutaneous coronary revascularization
OBJECTIVES: To compare outcomes of two different revascularization strategies in chronic kidney disease (CKD) patients: coronary artery bypass grafting (CABG) versus percutaneous coronary intervention (PCI). METHODS: We conducted this meta-analysis according to Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines and registered with PROSPERO (CRD42021238659), evaluated studies comparing CABG and PCI in patients with CAD and CKD (defined by KDIGO guidelines). Data were extracted from PubMed, EMBASE and Cochrane from 2000 to 2023. The primary end-point was long-term major adverse cardiovascular and cerebrovascular event rates, with secondary end-points including 30-day mortality, stroke, myocardial infarction (MI) and repeat revascularization. Statistical analyses included Kaplan–Meier estimations, Cox regression, and meta-regression to address heterogeneity. Publication bias was assessed via funnel plots. No funding was received, and the authors report no conflicts of interest. RESULTS: We included 33 studies with 402 300 patients (eGFR <60 ml/min/1.73 m2). The cohort comprised 132 314 coronary artery bypass graft and 269 986 PCI patients. Over 3 years, coronary artery bypass group provided protection against major adverse cardiac and cerebrovascular events, MI, and repeat revascularization compared to PCI. However, PCI showed better short-term outcomes, including lower 30-day mortality. Coronary artery bypass group was linked to a higher stroke risk over the 3-year follow-up. CONCLUSIONS: Revascularization strategies for CKD and coronary artery disease patients should balance PCI's short-term benefits with CABG’s long-term advantages.
- Top Cited PapersOpen Access
- 18 February 2025
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 35 (5) , 297-308
Cardiac tumors: Updated classifications and main clinico-pathologic findings
- 18 February 2025
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 35 (5) , 297-308
Top Cited PapersOpen AccessCardiac tumors: Updated classifications and main clinico-pathologic findings
- Open Access
- 1 January 2024
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 2024 (1)
Implementation of Robotic Coronary Surgery after Established Mitral Robotic Program
Aims. We described our advancement in the field of robotic cardiac surgery, particularly in the context of coronary revascularization. We will outline how the application of the Da Vinci® X Surgical System in coronary surgery is safe, feasible, and reproducible after an adequate familiarization with the docking system, that could come from a previous mitral valve robotic program, and after a sufficient learning time period. Methods. Between February 2021 and December 2023, a cohort of 33 patients underwent coronary artery revascularization surgery, involving robotic harvesting of the left mammary artery and off‐pump hand‐direct bypass to the left descending coronary artery or marginal coronary artery. In cases of hybrid revascularization, percutaneous coronary intervention with drug‐eluting stent placement was performed either before or after surgery. Results. There were no mortalities within 30 days and at 1 year of follow‐up after surgery. Notably, 70% of patients were extubated in the operating room immediately following the surgical procedure. The median postoperative mechanical ventilation time was 0 [0–4] hours, and the median length of stay in the intensive care unit was 21 [20–48] hours. A progressive reduction of the console and instrumental Da Vinci® X Surgical System was underling after the 21st patient. Conclusion. The promising outcomes observed in this series highlight that robotic‐assisted coronary artery bypass represents a well‐established technique that could be reproducible, especially when integrated into a hybrid strategy. Initiating a program in robotic‐assisted coronary artery bypass surgery can be effectively attained in particularly when a well‐established background in Da Vinci® X Surgical System utilization is achieved.
- 1 January 2024
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 2024 (1)
Open AccessImplementation of Robotic Coronary Surgery after Established Mitral Robotic Program
Aims. We described our advancement in the field of robotic cardiac surgery, particularly in the context of coronary revascularization. We will outline how the application of the Da Vinci® X Surgical System in coronary surgery is safe, feasible, and reproducible after an adequate familiarization with the docking system, that could come from a previous mitral valve robotic program, and after a sufficient learning time period. Methods. Between February 2021 and December 2023, a cohort of 33 patients underwent coronary artery revascularization surgery, involving robotic harvesting of the left mammary artery and off‐pump hand‐direct bypass to the left descending coronary artery or marginal coronary artery. In cases of hybrid revascularization, percutaneous coronary intervention with drug‐eluting stent placement was performed either before or after surgery. Results. There were no mortalities within 30 days and at 1 year of follow‐up after surgery. Notably, 70% of patients were extubated in the operating room immediately following the surgical procedure. The median postoperative mechanical ventilation time was 0 [0–4] hours, and the median length of stay in the intensive care unit was 21 [20–48] hours. A progressive reduction of the console and instrumental Da Vinci® X Surgical System was underling after the 21st patient. Conclusion. The promising outcomes observed in this series highlight that robotic‐assisted coronary artery bypass represents a well‐established technique that could be reproducible, especially when integrated into a hybrid strategy. Initiating a program in robotic‐assisted coronary artery bypass surgery can be effectively attained in particularly when a well‐established background in Da Vinci® X Surgical System utilization is achieved.
- Open Access
Learning Curve Analysis of Robotic-Assisted Mitral Valve Repair with COVID-19 Exogenous Factor: A Single Center Experience
Background and objective Renewed interest in robot-assisted cardiac procedures has been demonstrated by several studies. However, concerns have been raised about the need for a long and complex learning curve. In addition, the COVID-19 pandemic in 2020 might have affected the learning curve of these procedures. In this study, we investigated the impact of COVID-19 on the learning curve of robotic-assisted mitral valve surgery (RAMVS). The aim was to understand whether or not the benefits of RAMVS are compromised by its learning curve. Materials and Methods Between May 2019 and March 2023, 149 patients underwent RAMVS using the Da Vinci® X Surgical System at the Humanitas Gavazzeni Hospital, Bergamo, Italy. The selection of patients enrolled in the study was not influenced by case complexity. Regression models were used to formalize the learning curves, where preoperative data along with date of surgery and presence of COVID-19 were treated as the input covariates, while intraoperative and postoperative data were analyzed as output variables. Results The age of patients was 59.1 ± 13.3 years, and 70.5% were male. In total, 38.2% of the patients were operated on during the COVID-19 pandemic. The statistical analysis showed the positive impact of the learning curve on the trend of postoperative parameters, progressively reducing times and other key indicators. Focusing on the COVID-19 pandemic, statistical analysis did not recognize an impact on postoperative outcomes, although it became clear that variables not directly related to the intervention, especially ICU hours, were strongly influenced by hospital logistics during COVID-19. Conclusions Understanding the learning curve of robotic surgical procedures is essential to ensure their effectiveness and benefits. The learning curve involves not only surgeons but also other health care providers, and establishing a stable team in the early stage, as in our case, is important to shorten the duration. In fact, an exogenous factor such as the COVID-19 pandemic did not affect the robotic program despite the fact that the pandemic occurred early in the program.
Open AccessLearning Curve Analysis of Robotic-Assisted Mitral Valve Repair with COVID-19 Exogenous Factor: A Single Center Experience
Background and objective Renewed interest in robot-assisted cardiac procedures has been demonstrated by several studies. However, concerns have been raised about the need for a long and complex learning curve. In addition, the COVID-19 pandemic in 2020 might have affected the learning curve of these procedures. In this study, we investigated the impact of COVID-19 on the learning curve of robotic-assisted mitral valve surgery (RAMVS). The aim was to understand whether or not the benefits of RAMVS are compromised by its learning curve. Materials and Methods Between May 2019 and March 2023, 149 patients underwent RAMVS using the Da Vinci® X Surgical System at the Humanitas Gavazzeni Hospital, Bergamo, Italy. The selection of patients enrolled in the study was not influenced by case complexity. Regression models were used to formalize the learning curves, where preoperative data along with date of surgery and presence of COVID-19 were treated as the input covariates, while intraoperative and postoperative data were analyzed as output variables. Results The age of patients was 59.1 ± 13.3 years, and 70.5% were male. In total, 38.2% of the patients were operated on during the COVID-19 pandemic. The statistical analysis showed the positive impact of the learning curve on the trend of postoperative parameters, progressively reducing times and other key indicators. Focusing on the COVID-19 pandemic, statistical analysis did not recognize an impact on postoperative outcomes, although it became clear that variables not directly related to the intervention, especially ICU hours, were strongly influenced by hospital logistics during COVID-19. Conclusions Understanding the learning curve of robotic surgical procedures is essential to ensure their effectiveness and benefits. The learning curve involves not only surgeons but also other health care providers, and establishing a stable team in the early stage, as in our case, is important to shorten the duration. In fact, an exogenous factor such as the COVID-19 pandemic did not affect the robotic program despite the fact that the pandemic occurred early in the program.
- 16 November 2022
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 24 (3) , 184-190
Comparative myocardial protection of endoaortic balloon versus external clamp in minimally invasive mitral valve surgery
Aims: Minimally invasive mitral valve surgery leads to shorter postoperative recovery time, cosmetic advantages and significant pain reduction compared with the standard sternotomy approach. Both an external aortic clamp and an endoaortic balloon occlusion can be used to manage the ascending aorta and the myocardial protection. In this study, we aimed to compare these two strategies in terms of effectiveness of myocardial protection and associated early postoperative outcomes. Methods: We investigated the retrospective records of prospectively collected data of patients treated by minimally invasive mitral valve surgery from March 2014 to June 2019. A total of 180 cases (78 in the external aortic clamp group and 102 in the endoaortic balloon clamp group) were collected. A propensity weighting analysis was adopted to adjust for baseline variables. Results: The endoaortic balloon clamp presented higher EuroSCORE II (higher reoperative surgery rate). The intra- and postoperative data were similar between the two groups: the postoperative troponin-I levels, peak of serum lactates and rate of myocardial infarction were also comparable. The endoaortic clamp group recorded longer operative, cardiopulmonary bypass and cross-clamp times. The external clamp group showed a higher rate of postoperative atrial fibrillation and conduction block. Conclusions: In experienced centers, the use of the endoaortic balloon clamp is safe, reproducible and comparable to the external aortic clamp regarding the effectiveness of myocardial protection: its employment might facilitate minimally invasive mitral valve surgery.
- 16 November 2022
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 24 (3) , 184-190
Comparative myocardial protection of endoaortic balloon versus external clamp in minimally invasive mitral valve surgery
Aims: Minimally invasive mitral valve surgery leads to shorter postoperative recovery time, cosmetic advantages and significant pain reduction compared with the standard sternotomy approach. Both an external aortic clamp and an endoaortic balloon occlusion can be used to manage the ascending aorta and the myocardial protection. In this study, we aimed to compare these two strategies in terms of effectiveness of myocardial protection and associated early postoperative outcomes. Methods: We investigated the retrospective records of prospectively collected data of patients treated by minimally invasive mitral valve surgery from March 2014 to June 2019. A total of 180 cases (78 in the external aortic clamp group and 102 in the endoaortic balloon clamp group) were collected. A propensity weighting analysis was adopted to adjust for baseline variables. Results: The endoaortic balloon clamp presented higher EuroSCORE II (higher reoperative surgery rate). The intra- and postoperative data were similar between the two groups: the postoperative troponin-I levels, peak of serum lactates and rate of myocardial infarction were also comparable. The endoaortic clamp group recorded longer operative, cardiopulmonary bypass and cross-clamp times. The external clamp group showed a higher rate of postoperative atrial fibrillation and conduction block. Conclusions: In experienced centers, the use of the endoaortic balloon clamp is safe, reproducible and comparable to the external aortic clamp regarding the effectiveness of myocardial protection: its employment might facilitate minimally invasive mitral valve surgery.
- Open Access
- 30 October 2021
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 37 (1) , 165-173
Prognostic value of SARS‐CoV‐2 on patients undergoing cardiac surgery
Objective To analyze Italian Cardiac Surgery experience during the pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) identifying risk factors for overall mortality according to coronavirus disease 2019 (COVID-19) status. Methods From February 20 to May 31, 2020, 1354 consecutive adult patients underwent cardiac surgery at 22 Italian Centers; 589 (43.5%), patients came from the red zone. Based on COVID-19 status, 1306 (96.5%) were negative to SARS-CoV-2 (COVID-N), and 48 (3.5%) were positive to SARS-CoV-2 (COVID-P); among the COVID-P 11 (22.9%) and 37 (77.1%) become positive, before and after surgery, respectively. Surgical procedures were as follows: 396 (29.2%) isolated coronary artery bypass grafting (CABG), 714 (52.7%) isolated non-CABG procedures, 207 (15.3%) two associate procedures, and three or more procedures in 37 (2.7%). Heart failure was significantly predominant in group COVID-N (10.4% vs. 2.5%, p = .01). Results Overall in-hospital mortality was 1.6% (22 cases), being significantly higher in COVID-P group (10 cases, 20.8% vs. 12, 0.9%, p < .001). Multivariable analysis identified COVID-P condition as a predictor of in-hospital mortality together with emergency status. In the COVID-P subgroup, the multivariable analysis identified increasing age and low oxygen saturation at admission as risk factors for in-hospital mortality. Conclusion As expected, SARS-CoV-2 infection, either before or soon after cardiac surgery significantly increases in-hospital mortality. Moreover, among COVID-19-positive patients, older age and poor oxygenation upon admission seem to be associated with worse outcomes.
- 30 October 2021
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 37 (1) , 165-173
Open AccessPrognostic value of SARS‐CoV‐2 on patients undergoing cardiac surgery
Objective To analyze Italian Cardiac Surgery experience during the pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) identifying risk factors for overall mortality according to coronavirus disease 2019 (COVID-19) status. Methods From February 20 to May 31, 2020, 1354 consecutive adult patients underwent cardiac surgery at 22 Italian Centers; 589 (43.5%), patients came from the red zone. Based on COVID-19 status, 1306 (96.5%) were negative to SARS-CoV-2 (COVID-N), and 48 (3.5%) were positive to SARS-CoV-2 (COVID-P); among the COVID-P 11 (22.9%) and 37 (77.1%) become positive, before and after surgery, respectively. Surgical procedures were as follows: 396 (29.2%) isolated coronary artery bypass grafting (CABG), 714 (52.7%) isolated non-CABG procedures, 207 (15.3%) two associate procedures, and three or more procedures in 37 (2.7%). Heart failure was significantly predominant in group COVID-N (10.4% vs. 2.5%, p = .01). Results Overall in-hospital mortality was 1.6% (22 cases), being significantly higher in COVID-P group (10 cases, 20.8% vs. 12, 0.9%, p < .001). Multivariable analysis identified COVID-P condition as a predictor of in-hospital mortality together with emergency status. In the COVID-P subgroup, the multivariable analysis identified increasing age and low oxygen saturation at admission as risk factors for in-hospital mortality. Conclusion As expected, SARS-CoV-2 infection, either before or soon after cardiac surgery significantly increases in-hospital mortality. Moreover, among COVID-19-positive patients, older age and poor oxygenation upon admission seem to be associated with worse outcomes.
- Open Access
- 25 June 2021
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 36 (9) , 3308-3316
A multicentre roadmap to restart elective cardiac surgery after COVID‐19 peak in an Italian epicenter
Background During the Italian Phase-2 of the coronavirus pandemic, it was possible to restart elective surgeries. Because hospitals were still burdened with coronavirus disease 2019 (COVID-19) patients, it was focal to design a separate “clean path” for the surgical candidates and determine the possible effects of major surgery on previously infected patients. Methods From May to July 2020 (postpandemic peak), 259 consecutive patients were scheduled for elective cardiac surgery in three different centers. Our original roadmap with four screening steps included: a short item questionnaire (STEP-1), nasopharyngeal swab (NP) (STEP-2), computed tomography (CT)-scan using COVID-19 reporting and data system (CO-RADS) scoring (STEP-3), and final NP swab before discharge (STEP-4). Results Two patients (0.8%) resulted positive at STEP-2: one patient was discharged home for quarantine, the other performed a CT-scan (CO-RADS: 75 years: odds ratio [OR]: 2.6; 95% confidence interval [CI]: 1.25–5.57; p = 0.011; CPB >90 min. OR: 4.3; 95% CI: 1.84–10.16; p = 0.001). At 30 days, no periprocedural contagion and rehospitalization for COVID-19 infections were reported. Conclusions Our structured roadmap supports the safe restarting of an elective cardiac surgery list after a peak of a still ongoing COVID-19 pandemic in an epicenter area. Mild to moderate CT residuals of coronavirus pneumonia do not justify elective cardiac surgery procrastination.
- 25 June 2021
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 36 (9) , 3308-3316
Open AccessA multicentre roadmap to restart elective cardiac surgery after COVID‐19 peak in an Italian epicenter
Background During the Italian Phase-2 of the coronavirus pandemic, it was possible to restart elective surgeries. Because hospitals were still burdened with coronavirus disease 2019 (COVID-19) patients, it was focal to design a separate “clean path” for the surgical candidates and determine the possible effects of major surgery on previously infected patients. Methods From May to July 2020 (postpandemic peak), 259 consecutive patients were scheduled for elective cardiac surgery in three different centers. Our original roadmap with four screening steps included: a short item questionnaire (STEP-1), nasopharyngeal swab (NP) (STEP-2), computed tomography (CT)-scan using COVID-19 reporting and data system (CO-RADS) scoring (STEP-3), and final NP swab before discharge (STEP-4). Results Two patients (0.8%) resulted positive at STEP-2: one patient was discharged home for quarantine, the other performed a CT-scan (CO-RADS: 75 years: odds ratio [OR]: 2.6; 95% confidence interval [CI]: 1.25–5.57; p = 0.011; CPB >90 min. OR: 4.3; 95% CI: 1.84–10.16; p = 0.001). At 30 days, no periprocedural contagion and rehospitalization for COVID-19 infections were reported. Conclusions Our structured roadmap supports the safe restarting of an elective cardiac surgery list after a peak of a still ongoing COVID-19 pandemic in an epicenter area. Mild to moderate CT residuals of coronavirus pneumonia do not justify elective cardiac surgery procrastination.
- 12 November 2020
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 22 (7) , 567-571
Pulmonary endarterectomy in the octogenarian population: safety and outcomes
Aims: Aim of the study was to verify the feasibility, safety and efficacy of pulmonary endarterectomy (PEA) in octogenarian patients with chronic thromboembolic pulmonary hypertension. Methods: We retrospectively analyzed 635 chronic thromboembolic pulmonary hypertension patients who underwent PEA at our center and were followed-up for at least 1 year. The end-points of the study were in-hospital mortality, hemodynamic results at 1 year and long-term survival. Results: In-hospital mortality was 4, 10 and 17%, respectively, for 259 patients under the age of 60 years, 352 aged between 60 and 79 years and 24 octogenarians (P = 0.006 octogenarians vs. P = 0.021 and P < 0.001, respectively). At 1 year, the improvement in cardiac index was lower and the distance walked in 6 min was poorer for octogenarians than for the other two groups (both P = 0.001). Survival after hospital discharge was similar over a median follow-up period of 59 months (P = 0.113). Although in-hospital mortality and long-term survival are similar in octogenarians as compared with patients aged between 60 and 79, the improvement in cardiac index and in functional capacity at 1 year are lower in this very elderly population. Conclusion: Age over 80 years should not be a contraindication to PEA surgery in selected patients operated on in referral centers.
- 12 November 2020
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 22 (7) , 567-571
Pulmonary endarterectomy in the octogenarian population: safety and outcomes
Aims: Aim of the study was to verify the feasibility, safety and efficacy of pulmonary endarterectomy (PEA) in octogenarian patients with chronic thromboembolic pulmonary hypertension. Methods: We retrospectively analyzed 635 chronic thromboembolic pulmonary hypertension patients who underwent PEA at our center and were followed-up for at least 1 year. The end-points of the study were in-hospital mortality, hemodynamic results at 1 year and long-term survival. Results: In-hospital mortality was 4, 10 and 17%, respectively, for 259 patients under the age of 60 years, 352 aged between 60 and 79 years and 24 octogenarians (P = 0.006 octogenarians vs. P = 0.021 and P < 0.001, respectively). At 1 year, the improvement in cardiac index was lower and the distance walked in 6 min was poorer for octogenarians than for the other two groups (both P = 0.001). Survival after hospital discharge was similar over a median follow-up period of 59 months (P = 0.113). Although in-hospital mortality and long-term survival are similar in octogenarians as compared with patients aged between 60 and 79, the improvement in cardiac index and in functional capacity at 1 year are lower in this very elderly population. Conclusion: Age over 80 years should not be a contraindication to PEA surgery in selected patients operated on in referral centers.